DAVIES, Gareth Charles Glyndwr,ROBERTS, Scott John
申请号：
AU2019220407
公开号：
AU2019220407A1
申请日:
2019.02.14
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
The present invention relates to methods for the treatment of a bone fracture or bone defect. The invention discloses the effective use of an anti-gremlin-1 antibody to accelerate the healing and bridging of bone tissue in segmental gap defects； and demonstrates that inhibitors of gremlin-1 activity may provide improved therapies for treating or preventing fracture non-union.
